Grove raised $4.9M in Seed funding led by A* to scale its team and product for clinical trial management.
Grove raised $4.9M in Seed funding led by A* to scale its team and product for clinical trial management.
01/09/25, 9:48 AM
Location
san franciscoMoney raised
$4.9 million
Industry
machine learning
artificial intelligence
biotechnology
health care
Investors
Till Pieper, Phuc Truong, Chloe Yoo, Ajit Baid, Upfront Ventures, Pear Vc, Life X Ventures, Afore Capital, A*
Grove, based in San Francisco, CA, has raised $4.9M in Seed funding to enhance its clinical trial management platform. The funding round was led by A* with participation from several prominent investors. Grove aims to redefine clinical trials into participant-centered ecosystems using real-time data.
Company Info
Location
san francisco, california, united states
Additional Info
Grove AI revolutionizes clinical trials with its AI-powered participant relationship management (PRM) platform, delivering actionable insights and accelerating critical trial processes. Grove empowers research organizations to streamline operations, engage participants, and accelerate life-saving therapies. With Grove, clinical trials shift from cumbersome, manual workflows to adaptive, data-driven ecosystems that operate at the speed of innovation—bringing life-saving treatments to patients faster than ever.